Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-09-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for amoxicillin and clavulanate potassium submitted by Northstar RxLLC, resulting in updated labelin…
-
FDA label_change · 2019-09-20FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)
The FDA approved a supplemental application for ertapenem (ERTAPENEM SODIUM) submitted by ENDO USA, Inc.
-
FDA label_change · 2016-08-23FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium submitted by Hikma Pharmaceuticals USA Inc., updating the …
-
FDA label_change · 2015-03-16FDA Approved: AUGMENTIN ES-600 — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for AUGMENTIN ES-600 by USAntibiotics, LLC, updating the product labeling.
-
FDA label_change · 2014-09-22FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium filed by Northstar RxLLC, resulting in a label update …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.